Philip Ross

Phil Ross, joined Jefferies as Vice Chairman and Chairman of Global Healthcare Investment Banking, based in New York in 2024. Dr. Ross is a seasoned healthcare investment banker and has advised some of the most notable global biopharmaceutical companies, including Celgene, AbbVie, Merck. Since joining Jefferies, he has advised on the sale of Intra-Cellular to Johnson and Johnson, Blueprint to Sanofi, Merus to Ganmab and Ventyx to Lilly.

Prior to Jefferies, Phil spent 27+ years at J.P. Morgan most recently as Global Chair of Investment Banking.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.